188 related articles for article (PubMed ID: 30858288)
21. Pelvic drainage during removal of dialysis catheter decreases the risk of subsequent intra-abdominal complications in refractory peritoneal dialysis-related peritonitis.
Hsu CY; Huang WC; Huang CK; Huang CW; Chou NH; Lee PT; Fang HC; Chou KJ; Chen CL
Nephrology (Carlton); 2015 Nov; 20(11):855-61. PubMed ID: 25988239
[TBL] [Abstract][Full Text] [Related]
22. Salvage of the peritoneal dialysis catheter in
van Eck van der Sluijs A; Eekelschot KZ; Frakking FN; Haas PA; Boer WH; Abrahams AC
Perit Dial Int; 2021 Jan; 41(1):110-114. PubMed ID: 32400305
[No Abstract] [Full Text] [Related]
23. Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis.
Alvarez Nadal M; Sosa Barrios RH; Burguera Vion V; Campillo Trapero C; Fernández Lucas M; Rivera Gorrín ME
Kidney Med; 2020; 2(5):650-651. PubMed ID: 33089141
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
25. Intra-catheter leukocyte culture to monitor hemodialysis catheter colonization. A prospective study to prevent catheter-related bloodstream infections.
Del Pozo JL; Aguinaga A; Garcia-Fernandez N; Hernaez S; Serrera A; Alonso M; Ramos A; Guillen-Grima F; Leiva J
Int J Artif Organs; 2008 Sep; 31(9):820-6. PubMed ID: 18924094
[TBL] [Abstract][Full Text] [Related]
26. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis.
Girard LP; Ceri H; Gibb AP; Olson M; Sepandj F
Perit Dial Int; 2010; 30(6):652-6. PubMed ID: 21148059
[TBL] [Abstract][Full Text] [Related]
27. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
Beigi AA; Khansoltani S; Masoudpour H; Atapour AA; Eshaghian A; Khademi EF
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):54-8. PubMed ID: 20061693
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
29. Patient's cells colonize the biofilm of Tenckhoff catheters used in peritoneal dialysis.
Guerra e Silva A; Lima MG; Takiya CM; Andrade LR
Biofouling; 2011 Jul; 27(6):603-8. PubMed ID: 21985293
[TBL] [Abstract][Full Text] [Related]
30. Erosion of the Silicone Peritoneal Dialysis Catheter with the Use of Gentamicin Cream at the Exit Site.
Gardezi AI; Schlageter KW; Foster DM; Astor BC; Chan MR; Waheed S
Adv Perit Dial; 2016; 32():15-18. PubMed ID: 28988584
[TBL] [Abstract][Full Text] [Related]
31. Prevention and management of hemodialysis catheter infections.
Ramanathan V; Darouiche RO
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1447-55. PubMed ID: 23253322
[TBL] [Abstract][Full Text] [Related]
32. Prevention of peritoneal dialysis-related infections.
Nessim SJ
Semin Nephrol; 2011 Mar; 31(2):199-212. PubMed ID: 21439433
[TBL] [Abstract][Full Text] [Related]
33. Strategies to universally improve peritonitis rates, including use of dialysis solutions with low glucose degradation products.
Diaz-Buxo JA; Himmele R
Adv Perit Dial; 2010; 26():37-40. PubMed ID: 21348377
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic locks for the treatment of catheter-related blood stream infection: Still more hope than data.
Labriola L
Semin Dial; 2019 Sep; 32(5):402-405. PubMed ID: 30950116
[TBL] [Abstract][Full Text] [Related]
35. Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.
Klimek K; Aresté Fosalba N; Ramírez López MÁ; Gómez Castilla AC; Salgueira Lazo M
Nefrologia (Engl Ed); 2020; 40(2):197-201. PubMed ID: 31208832
[TBL] [Abstract][Full Text] [Related]
36. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro.
Kite P; Eastwood K; Sugden S; Percival SL
J Clin Microbiol; 2004 Jul; 42(7):3073-6. PubMed ID: 15243062
[TBL] [Abstract][Full Text] [Related]
37. Biofilms in peritoneal dialysis.
Dasgupta MK; Larabie M
Perit Dial Int; 2001; 21 Suppl 3():S213-7. PubMed ID: 11887824
[TBL] [Abstract][Full Text] [Related]
38. Central venous catheters and biofilms: where do we stand in 2017?
Gominet M; Compain F; Beloin C; Lebeaux D
APMIS; 2017 Apr; 125(4):365-375. PubMed ID: 28407421
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
40. Using detachment-promoting agents for the prevention of chronic peritoneal dialysis-associated infections.
Branger B; Marion K; Bergeron E; Perret C; Zabadani B; Reboul P; Freney J
Artif Organs; 2008 Dec; 32(12):918-24. PubMed ID: 19133019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
